Marshall Edwards (MSHL) Submits IND to FDA for ME-344; Commences 4th Cohort ME-143 Phase I Dosing
Go back to Marshall Edwards (MSHL) Submits IND to FDA for ME-344; Commences 4th Cohort ME-143 Phase I Dosing| MARSHALL EDWARDS (NASDAQ: MSHL) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $3.28 | |||
| Open | $1.82 | 52 Week Low | $0.41 | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $-0.64 | |||
| Volume | 989,439 | |||||
